Results 31 to 40 of about 53,966 (218)
Transfer of single dose of intravitreal injection of ranibizumab and bevacizumab into milk of sheep [PDF]
International Journal of Ophthalmology, 2017 AIM: To investigate whether single-dose intravitreal injections of bevacizumab and ranibizumab transfer into milk. METHODS: This study included lactating 12 sheep and a single 3-month old suckling lamb of each sheep. Two groups consisting of 6 sheep and
Tugba Cakmak Argun +7 more
doaj +1 more source
Intravitreal Bevacizumab for Filtering Surgery
Ophthalmic Research, 2007 <i>Background:</i> It was the aim of this study to report on the intravitreal use of bevacizumab as antiproliferative agent in combination with filtering surgery. <i>Methods:</i> The clinical interventional case series study included 2 patients (2 eyes) who underwent standard antiglaucomatous penetrating filtering surgery ...
Jost B, Jonas +2 more
openaire +2 more sources
Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation [PDF]
, 2014 Victor M Villegas,1 Aaron S Gold,1 Audina M Berrocal,2 Timothy G Murray11Ocular Oncology and Retina, Miami, FL, USA; 2Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USAPurpose: To ...
Berrocal AM +7 more
core +1 more source
American Journal of Ophthalmology Case Reports, 2018 Purpose: To evaluate the effect of salvage therapy with bevacizumab after laser photocoagulation for infants with recurrence of zone I aggressive-posterior retinopathy of prematurity (AP-ROP). Methods: This was a retrospective case series documenting the
Yoko Fukushima +4 more
doaj +1 more source
Surgical management of submacular hemorrhage due to n-AMD: a comparison of three surgical methods
International Journal of Retina and Vitreous, 2020 Background To compare and assess the efficacy of three surgical methods for the treatment of acute submacular hemorrhage (ASH): pneumatic displacement with C2F6, in combination with intravitreal injection of bevacizumab and rtPA, pars plana vitrectomy ...
Carsten Grohmann +6 more
doaj +1 more source
Erectile dysfunction following intravitreal bevacizumab
Middle East African Journal of Ophthalmology, 2010 Despite initial concerns regarding systemic complications, the use of intravitreal antivascular endothelial growth factor (anti-VEGF) agents for ocular disease is rapidly expanding worldwide, in terms of both the number of patients injected and its indications.
Yohendran, Jayshan, Chauhan, Devinder
openaire +3 more sources
Response of diabetic papillopathy to intravitreal bevacizumab
Middle East African Journal of Ophthalmology, 2011 Diabetic papillopathy is an uncommon hyperemic optic disc swelling that occurs in patients with long-standing diabetes, is typically self-resolving with minimal effect on vision, and is likely ischemic in origin. The purpose of the current report is to document the response of diabetic papillopathy to intravitreal injection of bevacizumab (Avastin ...
Al-Dhibi, Hassan, Khan, Arif O.
openaire +3 more sources
Intravitreal Bevacizumab in Retinopathy of Prematurity
Asia-Pacific Journal of Ophthalmology, 2014 This article is aimed to review and summarize the indications, outcomes and safety profiles regarding the use of intravitreal bevacizumab in patients with retinopathy of prematurity (ROP) as reported in previous studies with no intention to compare the efficacy between intravitreal bevacizumab and laser photocoagulation.Literature search was conducted ...
Dini, Hapsari, Rita S, Sitorus
openaire +2 more sources
Intravitreal administration of bevacizumab: pros and cons [PDF]
DARU Journal of Pharmaceutical Sciences, 2015 Bevacizumab uses Bevacizumab (Avastin®, Genethech, Inc.) is a humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF). It was first approved by the US food and drug administration for metastatic colorectal cancer and subsequently for cervical/ovarian/fallopian tube cancers, glioblastoma, non-small cell lung cancer, and ...
Dashti-Khavidaki, Simin +1 more
openaire +2 more sources
Recurrent fungal endophthalmitis after intravitreal injections of bevacizumab
American Journal of Ophthalmology Case Reports, 2020 Purpose: We intend to describe an uncommon case of recurrent post-cataract fungal endophthalmitis after intravitreal injections of Bevacizumab. Observations: A 73-year-old male, who underwent an uncomplicated cataract surgery 8 months ago, presented to ...
Alaa Din Abdin +4 more
doaj +1 more source